1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. REGENXBIO INC
16.01 0.99 (6.59%)
653.4K
XNAS Volume

XNAS 22 Jan, 2026 3:54 PM (EST)

Watchlist

Portfolio

Alert

Regenxbio Inc - RGNX - stock price prediction, stock price target, analyst ratings from 11 analysts

Regenxbio Inc has a share price target of US$ 31, revenue growth forecast of 143.5%, and profit growth estimate of 31.6% for FY25, based on top 11 analyst calls.